EG ·
virokan 400 mg cap
virokan 400 mg cap
Composition
These source-reported data require scientific review and are not treatment advice.
RIBAVIRIN
· AMOUNT_PER_UNIT
RIBAVIRIN
· AMOUNT_PER_UNIT
Registration
Packages and prices
Explainable alternatives
Candidates are informational and are not automatic authorization for substitution or dispensing.
| Product | Match | Differences | Price |
|---|---|---|---|
| VIRIN 200MG 12/CAP | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| ribavirin 400 mg 12 cap | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| HEPAVERIN 200 MG 10 CAP | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| VIRACURE 200MG 12/CAP | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| PANVIRIN 200 MG 10 CAP | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| PANVIRIN 400MG 10 CAP | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| RIBA 200 MG 10 CAP | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| RIBAVIRIN 100 ML SYRUP | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| VIROKAN 400 MG 12 CAP | SAME_ACTIVE_INGREDIENT_SET | strength_or_basis | — EGP |
| HEPATOVIRIN 400 MG 30 CAP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis | — EGP |
| RIBA 400mg 10CAP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| VIRACURE 400 MG 12 CAP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |